Glucocorticoid-induced myopathy
Steroid-related proximal weakness · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A common complication of prolonged or high-dose corticosteroid therapy producing painless proximal muscle weakness, typically of the hip girdle, with a normal creatine kinase. The key challenge is distinguishing it from a flare of the underlying inflammatory myopathy, which would warrant more steroid rather than less.
Red flags
- Rising CK (suggests myositis flare, not steroid myopathy)
- Rapidly progressive weakness
- Respiratory or bulbar muscle involvement
- Marked muscle pain or tenderness
- Falls and loss of mobility
Assessment
Differential diagnosis
- Active inflammatory myopathy flare
- Disuse atrophy / deconditioning
- Hypothyroid or other endocrine myopathy
- Electrolyte disturbance (hypokalaemia, hypophosphataemia)
- Statin / drug-induced myopathy
- Critical illness myopathy
Investigations
- Creatine kinase (characteristically normal in steroid myopathy)
- Electrolytes including potassium, phosphate, magnesium
- Thyroid function
- EMG (myopathic without irritability; may be normal)
- Review of steroid dose, duration and timeline against symptom onset
- Muscle MRI/biopsy only if diagnosis remains unclear
Management
- Correlate the timeline of weakness with steroid dose and duration
- Use a normal CK and absence of inflammatory features to differentiate from a myositis flare
- Exclude electrolyte, thyroid and other drug causes of weakness
- Reduce the glucocorticoid dose to the lowest effective level and consider steroid-sparing agents
- Switch from fluorinated steroids (dexamethasone, triamcinolone) to non-fluorinated where possible
- Encourage graded resistance and aerobic exercise / physiotherapy
- Ensure adequate protein intake and treat vitamin D deficiency
- Monitor strength to confirm improvement as steroids are reduced (confirms the diagnosis)
Drugs & doses
Reduce prednisolone to lowest effective dose; aim to taper where disease allows
Switch fluorinated steroid to prednisolone (non-fluorinated) if feasible
Colecalciferol — 800-2000 units PO OD if vitamin D deficient
Steroid-sparing agent (e.g. methotrexate 15-25 mg weekly) to allow steroid reduction
Disposition
Outpatient management with steroid minimisation and physiotherapy; admission rarely required.
Complications & pitfalls
- Falls and fractures
- Loss of mobility and independence
- Difficulty distinguishing from myositis flare leading to inappropriate dose changes
- Deconditioning
Exam pearls
- Normal CK with proximal weakness in a steroid-treated patient points to steroid myopathy, not a flare
- Fluorinated steroids (dexamethasone, triamcinolone) are more myotoxic
- Improvement with dose reduction and exercise confirms the diagnosis retrospectively
- Rising CK should make you suspect active myositis instead
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.